Categorized by WHO as critically important antibiotics, third-generation cephalosporins (3GCs) are one of the latest therapeutic alternatives to fight severe infectious diseases in humans. Some antibiotics belonging to this class are prescribed to treat food-producing animals in specific pathological contexts. Preserving the effectiveness of 3GCs requires characterization and careful monitoring of 3GCs resistance and the identification and implementation of measures that can limit this antimicrobial resistance (AMR). Here, we characterized the 3GCs resistance in Escherichia coli isolated from diseased animals. Using data collected from broilers, hens, calves, piglets, sows, turkeys and ducks between 2006 and 2016 by the French surveillance network of AMR in pathogenic bacteria of animal origin (called RESAPATH), we investigated the dynamics of resistance to 3GCs. Our non-linear analysis applied to time series showed that the evolution of E. coli resistance to 3GCs is specific to each animal category. From 2006 to 2010, resistance to 3GCs increased for most animal categories. We observed peaks of high-level of resistance for hens (21.5% in 2010) and broilers (26.7% in 2011), whereas trends stayed below 10% for the other animal categories throughout the study period. Resistance later decreased and, since 2014, 3GCs resistance has dropped below 10% for all animal categories. The parallel between trends and measures to limit AMR over the period shed lights on the impact of practices changes, public policies (EcoAntibio Plan) and sector-led initiatives (moratorium in swine sector). Finally, they highlight the usefulness and importance of AMR surveillance networks in animal health, such as RESAPATH.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetmic.2018.07.025DOI Listing

Publication Analysis

Top Keywords

3gcs resistance
12
resistance 3gcs
12
animal categories
12
resistance
10
coli resistance
8
third-generation cephalosporins
8
food-producing animals
8
3gcs
8
measures limit
8
10% animal
8

Similar Publications

Management of Recurrent Ventriculoperitoneal Shunt Infections in Adult Patients.

Antibiotics (Basel)

January 2025

Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34303 Istanbul, Turkey.

The objective of this study was to evaluate the demographic, clinical, laboratory, and microbiological features of ventriculoperitoneal shunt (VPS) infections through a 13-year retrospective study. VPS bacterial agents and their antibiotic susceptibility were also investigated through the occurrence of single VPS (SVPS) and recurrent VPS (RVPS) infections. This study included 110 patients with SVPS infections and 55 patients with RVPS infections.

View Article and Find Full Text PDF

Hazard Characterization of Antibiotic-resistant Aeromonas spp. Isolated from Mussel and Oyster Shellstock Available for Retail Purchase in Canada.

J Food Prot

November 2024

Bureau of Microbial Hazards, Health Canada, 251 Sir Frederick Banting Driveway, A.L. 2204E, Ottawa, Ontario K1A 0K9, Canada. Electronic address:

Article Synopsis
  • The study investigates the presence of antimicrobial-resistant (AMR) bacteria in live mussels and oysters, emphasizing the risks these foods pose to human health.
  • Out of 180 samples tested, 52% contained third-generation cephalosporin-resistant bacteria, mainly from Serratia, Aeromonas, and Rahnella species.
  • Further genomic analysis of selected Aeromonas strains revealed multiple antibiotic resistance genes and mobile genetic elements, underscoring the complexities of assessing foodborne bacterial risks through genomic tools.
View Article and Find Full Text PDF

Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales.

Pharmacy (Basel)

September 2024

Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.

Article Synopsis
  • AmpC enzymes are beta-lactamases from Gram-negative bacteria, mainly Enterobacterales, that can cause resistance to key antibiotics like third-generation cephalosporins and piperacillin/tazobactam.
  • These enzymes can be either chromosomal or plasmid-encoded and can be overproduced during beta-lactam treatment, leading to increased resistance.
  • The review aims to gather important info on AmpC-producing Enterobacterales to help guide clinical treatment strategies, especially in complicated cases and regarding the use of safer antibiotic options.
View Article and Find Full Text PDF

Increased antimicrobial resistance (AMR) among bacteria underscores the need to strengthen AMR surveillance and promote data-based prescribing. To evaluate trends and associations between antimicrobial usage (AMU) and AMR, we explored a dataset of 34,672 bacterial isolates collected between 2015 and 2020 from clinical samples at the University Teaching Hospital (UTH) in Lusaka, Zambia. The most frequently isolated species were Escherichia coli (4,986/34,672; 14.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated factors that influence the susceptibility of third-generation cephalosporins (3GCs) in cases of bacteremia, using a case-case-control design.
  • Common risk factors for both 3GC susceptible and non-susceptible groups included prior antimicrobial therapy and recent hospitalization, while hospitalization in specific institutions was unique to the non-susceptible group.
  • The findings suggest that being hospitalized more than 14 days before developing bacteremia is linked to poorer outcomes, but implementing source control significantly improves treatment success.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!